End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.46 CNY | +2.96% | +5.62% | -51.25% |
26/06 | Walvax Biotechnology Ends Vaccine Development Deal With Abogen Biotechnology | MT |
18/06 | Walvax Terminates Coronavirus Vaccine Trials Due to Mutations | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.25% | 244.75Cr | |
+7.46% | 10TCr | |
+11.97% | 4.23TCr | |
-11.34% | 3.28TCr | |
+79.34% | 2.95TCr | |
-12.18% | 1.63TCr | |
+3.52% | 1.44TCr | |
-1.90% | 1.22TCr | |
+178.17% | 1.05TCr | |
+1.80% | 896.68Cr |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Buys Back 170,000 Shares; Stock Rises 3%